Meitheal Pharmaceuticals
Phase 3Meitheal Pharmaceuticals headquartered in Chicago, Illinois, with global strategic partners, Meitheal manufactures innovative biopharmaceutical products.
Founded
2017
Focus
Generic Drugs
About
Meitheal Pharmaceuticals headquartered in Chicago, Illinois, with global strategic partners, Meitheal manufactures innovative biopharmaceutical products.
Funding History
2Total raised: $45M
Series B$30MUndisclosedNov 15, 2021
Series A$15MUndisclosedMay 15, 2019
Company Info
TypePrivate
Founded2017
LocationChicago, United States
StagePhase 3
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile